current user: public




KOG0033
Query: [T] KOG0033 Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily, from COG0312

Results of FFAS03 search in PDB0312
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520
# Score Template Links and tools%idFirst MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGPPSTIKESSESSQTIDDNDSEKGGGQLKHENTVVRADGATGIVSSSNSSTASKSSSTNLSAQKQDIVRVTQTLLDAISCKDFETYTRLCDTSMTCFEPEALGNLIEGIEFHRFYFDGNRKNQVHTTMLNPNVHIIGEDAACVAYVKLTQFLDRNGEAHTRQSQESRVWSKKQGRWVCVHVHRSTQPSTNTTVSEFLast
1 -105.0002wel_A mol:protein length:327 CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE T  ali model follow..  79  1......SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLKKPDGVKESTESSN............................................................................................................................................................................................ 327
2 -105.0003bhh_A mol:protein length:295 Calcium/calmodulin-dependent protein kinase t  ali model follow..  80  1......SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLKGA............................................................................................................................................................................................................................ 295
3 -104.0003soa_A mol:protein length:444 Calcium/calmodulin-dependent protein kinase t  ali model follow..  61  2ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRKQEIIKVTEQLIEAISNGDFESYT----KMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVH-----------------TTILNPHIHLMGDESACIAYIR------------------------------------------------------ITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPS........ 444
4 -104.0002vz6_A mol:protein length:313 CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE T  ali model follow..  80  7LGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA............................................................................................................................................................................................................................ 307
5 -104.0003hzt_A mol:protein length:467 Calcium-dependent protein kinase 3  ali model follow..  29  1......GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCSQKGKHALTGALGNMKKFQSSQKLAQAAMLFMGTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQL----------LLSRERLLAAFQQFDSDGSGKITNEELGRVDDETWHQVLQECDKNN---DGEVDFEEFVEMMQK................................................................. 459
6 -104.0003i79_A mol:protein length:484 Calmodulin-domain protein kinase 1  ali model follow..  29  17VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDAHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKT----------LLSRERLERAFRMFDSDNSGKISSTELATVDSETWKSVLSEVDKNN---DGEVDFDEFQQMLLK................................................................. 480
7 -103.0003q5i_A mol:protein length:504 Protein kinase  ali model follow..  26  21VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKEERKELTDIFKKLDKNGDGQLDKKELIEGYNVELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQI----------LFSEERLRRAFNLFDTDKSGKITKEELANISEKTWNDVLGEADQNK---DNMIDFDEFVSMMHK................................................................. 491
8 -102.0002bdw_A mol:protein length:362 Hypothetical protein K11E8.1d  ali model follow..  99  20MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGPPSTIKESSESSQTIDDN................................................................................................................................................................................. 362
9 -102.0003hx4_A mol:protein length:508 Calmodulin-domain protein kinase 1  ali model follow..  29  41VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDAHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLS----------RERLERAFRMFDSDNSGKISSTELATVDSETWKSVLSEVDKNN---DGEVDFDEFQQMLLK................................................................. 504
10 -102.0002v7o_A mol:protein length:336 CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE T  ali model follow..  81  18..ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFS................................................................................................................................................................................................................ 328
11 -101.0003lij_A mol:protein length:494 Calcium/calmodulin dependent protein kinase w  ali model follow..  29  22ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESPSLANAIENMRKFQNSQKLAQAALLYMASQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFSEVDAILGAADFDRNGYIDYSEFVTVAMDRKS----------LLSKDKLESAFQKFDQDGNGKISVDELASLESKTWKEMISGIDSNN---DGDVDFEEFCKMIQK................................................................. 482
12 -101.0002jam_A mol:protein length:304 CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE T  ali model follow..  39  1.SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT-ALHRDIYPSVSLQIQKNFAKSKWRQAFNAAAVVHH................................................................................................................................................................................................................... 304
13 -101.0003igo_A mol:protein length:486 Calmodulin-domain protein kinase 1  ali model follow..  29  9..YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTI----------LLSRERMERAFKMFDKDGSGKISTKELFKIQMEELESIIEQVDNNK---DGEVDFNEFVEMLQN................................................................. 475
14 -100.0001a06_A mol:protein length:332 CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE  ali model follow..  39  9RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT-ALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRKLQLGHQPGGTGTDS..................................................................................................................................................................................................... 332
15 -99.9003dxn_A mol:protein length:287 Calmodulin-like domain protein kinase isoform  ali model follow..  40  8..LYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCS...................................................................................................................................................................................................................................................... 279
16 -99.6002jc6_A mol:protein length:334 CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE T  ali model follow..  38  13WKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE-SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDT-ALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRK--LHLGSSLDSSNA.................................................................................................................................................................................................. 334
17 -99.1002qg5_A mol:protein length:294 Calcium/calmodulin-dependent protein kinase  ali model follow..  35  11QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL................................................................................................................................................................................................................................................ 287
18 -99.1003ma6_A mol:protein length:298 Calmodulin-domain protein kinase 1  ali model follow..  41  17VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK...................................................................................................................................................................................................................................................... 290
19 -97.0003c0g_A mol:protein length:351 Peripheral plasma membrane protein CASK  ali model follow..  43  17..DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHSFYGDPPEELPDFSEDPTS................................................................................................................................................................................................. 351
20 -97.0003mfr_A mol:protein length:351 Peripheral plasma membrane protein CASK  ali model follow..  44  17..DDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHSFYGDPPEELPDFSEDPTS................................................................................................................................................................................................. 351
21 -96.0003tac_A mol:protein length:361 Peripheral plasma membrane protein CASK  ali model follow..  42  11MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHSFYGDPPEELPSEDPTSSGLLAAER........................................................................................................................................................................................... 355
22 -95.8001yrp_A mol:protein length:278 Death-associated protein kinase 3  ali model follow..  37  3STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA......................................................................................................................................................................................................................................................... 278
23 -95.4002j90_A mol:protein length:304 DEATH-ASSOCIATED PROTEIN KINASE 3  ali model follow..  36  13..YFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG............................................................................................................................................................................................................................................. 298
24 -95.1001wmk_A mol:protein length:321 Death-associated protein kinase 2  ali model follow..  34  3EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNAMVRRESVVNLENFRKQYVRRRWKLDFSIVSLCNH................................................................................................................................................................................................................... 318
25 -94.7003dfc_B mol:protein length:295 Death-associated protein kinase 1  ali model follow..  33  2TVFRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFEK....................................................................................................................................................................................................................................... 295
26 -94.6002x0g_A mol:protein length:334 DEATH-ASSOCIATED PROTEIN KINASE 1  ali model follow..  33  2TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDQALSRKASAVNMEKFKKFAARKKWKQSVRLISLCQRFLSRSNMSVARSD...................................................................................................................................................................................................... 334
27 -94.3003is5_A mol:protein length:285 Calcium-dependent protein kinase  ali model follow..  32  9..YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ......................................................................................................................................................................................................................................................... 278
28 -94.1002ya9_A mol:protein length:361 DEATH-ASSOCIATED PROTEIN KINASE 2  ali model follow..  32  3ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRRSST......................................................................................................................................................................... 360
29 -94.1002y0a_A mol:protein length:326 DEATH-ASSOCIATED PROTEIN KINASE 1  ali model follow..  31  5...RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT-------QQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQKIEWH.................................................................................................................................................................................................. 325
30 -94.0001z9x_A mol:protein length:321 Death-associated protein kinase 2  ali model follow..  35  3EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVLENFRKQYVRRRSKLAFSIVSLCNH................................................................................................................................................................................................................... 318
31 -93.7003lm0_A mol:protein length:327 Serine/threonine-protein kinase 17B  ali model follow..  30  13YFQSMENFNNFYILSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDENLFHPEETSSSSQTQDHSVRSSEDKTSKSS........................................................................................................................................................................................................................ 321
32 -93.3004A9R Entity 1(prereleased)  ali follow..  32  7MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGYNRAVDCWSLGVILFICLSGYPPFSEHTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENESTALPQVLAQPSTSRKRPREGEAE........................................................................................................................................................................................................... 326
33 -93.3002cn5_A mol:protein length:329 SERINE/THREONINE-PROTEIN KINASE CHK2  ali model follow..  32  7MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGYNRAVDCWSLGVILFICLSGYPPFSEHTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENESTALPQVLAQPSTSRKRPREGEAE........................................................................................................................................................................................................... 326
34 -93.3002w4o_A mol:protein length:349 CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE T  ali model follow..  42  38DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK--AANFVHMDTAQKKLQEFNARRKLKAAVKAVVASSR................................................................................................................................................................................................................... 341
35 -92.4001tki_A mol:protein length:321 TITIN  ali model follow..  24  1.....KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS----TKVIRTLKHRRYYHTLIKKDLNMVVSASCGGAIRSQKGVSVAKVKVA................................................................................................................................................................................................ 319
36 -92.4003kn5_A mol:protein length:325 Ribosomal protein S6 kinase alpha-5  ali model follow..  32  2...KDSPFYQHYDLDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDICVKATFHAFNKYKREGFCLQNVDK................................................................................................................................................................................................................... 324
37 -90.3003gok_A mol:protein length:334 MAP kinase-activated protein kinase 2  ali model follow..  32  25..KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASCPHIVRIVDVYENRKCLLIVMECLDGGELFSRIQDRGAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHSPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWEDVKEEMTSALATMR................................................................................................................................................................................................................... 334
38 -89.9001phk_A mol:protein length:298 PHOSPHORYLASE KINASE  ali model follow..  39  10..HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSELREATLKEVDILRKVSHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF................................................................................................................................................................................................................................................ 298
39 -89.6003fhr_A mol:protein length:336 MAP kinase-activated protein kinase 3  ali model follow..  31  13PEPKKYAVTDDYQLSKQLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGPHIVCILDVYENKRCLLIIMECMEGGELFSRIQERGDFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL-HTARVLQEDKDHWDEVKEEMTSALATMR................................................................................................................................................................................................................... 324
40 -88.5002hw6_A mol:protein length:307 MAP kinase-interacting serine/threonine-prote  ali model follow..  33  5..SLPGKFEDMYKLSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS--RVFREVETLYQCQNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNELTTPCGSAEYMAPEVVEATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG................................................................................................................................................................................................................................................... 307
41 -88.2003hko_A mol:protein length:345 Calcium/calmodulin-dependent protein kinase w  ali model follow..  31  11QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNGMTTKAGTPYFVAPEVLNNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM................................................................................................................................................................................................................................................. 338
42 -87.6002ac3_A mol:protein length:316 MAP kinase-interacting serine/threonine kinas  ali model follow..  34  5..SFSGRFEDVYQLQEDLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGELLTPCGSAEYMAPEVVEASIYDKRCDLWSLGVILYILLSGYPPFVGRCQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVL............................................................................................................................................................................................................................................ 314
43 -87.6002onl_C mol:protein length:406 MAP kinase-activated protein kinase 2  ali model follow..  29  61..KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASCPHIVRIVDVYENRKCLLIVMECLDGGELFSRIQDRGAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHSPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEA.................................................................................................................................................................................... 401
44 -86.7001kob_A mol:protein length:387 TWITCHIN  ali model follow..  31  36VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSAIGRIANFSSLRKHRPQEYQIYDDRKEAVPRFKLRPSLISS.................................................................................................................................................................................................... 381
45 -86.0003kga_A mol:protein length:299 MAP kinase-activated protein kinase 2  ali model follow..  31  11..KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASCPHIVRIVDVYENRKCLLIVMECLDGGELFSRIQDRGAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHSPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWEDVKEEMTSALATMR................................................................................................................................................................................................................... 299
46 -85.9002y7j_A mol:protein length:365 PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN,  ali model follow..  43  81..AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLEVREATRRETHILRQVAHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER......................................................................................................................................................................................................................................................... 359
47 -84.3003i6w_A mol:protein length:443 Serine/threonine-protein kinase Chk2  ali model follow..  34  142..VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFEADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVTAGYNRAVDCWSLGVILFICLSGYPPFSEHTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENESTALPQVL........................................................................................................................................................................................................................... 443
48 -84.2002wnt_A mol:protein length:330 RIBOSOMAL PROTEIN S6 KINASE  ali model follow..  32  12LYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR------DPSEEIEILLRYQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPELRICDFGFAKQLRENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKPTPQLKPIES............................................................................................................................................................................................................... 324
49 -84.0002qr7_A mol:protein length:342 Ribosomal protein S6 kinase alpha-3  ali model follow..  31  13LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNESIRICDFGFAKQLRENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLATYSALNRNQSPVLEPVGRSAQRRGIKKITST........................................................................................................................................................................................................ 340
50 -83.1001koa_A mol:protein length:491 TWITCHIN  ali model follow..  27  42VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGR-ISNYSSLRKHRPQEYSIRDAFWDRSEA....................................................................................................................................................................................... 375
51 -83.0002x4f_A mol:protein length:373 MYOSIN LIGHT CHAIN KINASE FAMILY MEMBER 4  ali model follow..  32  72VTAKQGAVNSFYTVSEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ---KKKNRGSDAQDFVTK............................................................................................................................................................................................................................. 367
52 -82.7003RNY Entity 1(prereleased)  ali follow..  33  14..HMNLVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR------DPSEEIEILLRYQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPELRICDFGFAKQLRENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKTYSALNSSKPTIESSILAQRRVRKLPSTT.......................................................................................................................................................................................................... 339
53 -78.7003r21_A mol:protein length:271 Serine/threonine-protein kinase 6  ali model follow..  31  11.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS................................................................................................................................................................................................................................................... 271
54 -78.5003coh_A mol:protein length:268 Serine/threonine-protein kinase 6  ali model follow..  31  8.........EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS................................................................................................................................................................................................................................................... 268
55 -78.4001mq4_A mol:protein length:272 AURORA-RELATED KINASE 1  ali model follow..  31  12.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS................................................................................................................................................................................................................................................... 272
56 -78.4003VAP Entity 1(prereleased)  ali follow..  31  12.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS................................................................................................................................................................................................................................................... 272
57 -78.3003d14_A mol:protein length:272 serine/threonine kinase 6  ali model follow..  31  12.........EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSNGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS................................................................................................................................................................................................................................................... 272
58 -78.2003qbn_A mol:protein length:281 Serine/threonine-protein kinase 6  ali model follow..  31  9.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSCHA-PSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 263
59 -78.1003cok_A mol:protein length:278 Serine/threonine-protein kinase PLK4  ali model follow..  33  11.........EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN........................................................................................................................................................................................................................................................ 269
60 -78.1002w1c_A mol:protein length:275 SERINE/THREONINE-PROTEIN KINASE 6  ali model follow..  31  11.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN........................................................................................................................................................................................................................................................ 266
61 -77.8003d5x_A mol:protein length:301 Polo-like kinase 1  ali model follow..  33  26.........KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG........................................................................................................................................................................................................................................................ 283
62 -77.8002h6d_A mol:protein length:276 5`-AMP-activated protein kinase catalytic sub  ali model follow..  37  12..........HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE-----LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD........................................................................................................................................................................................................................................................ 268
63 -77.7003zuu_A mol:protein length:362 SERINE/THREONINE-PROTEIN KINASE SRK2E  ali model follow..  26  10MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID---ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHLNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATV----------------PPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEIVYA...................................................................................................................................................... 361
64 -77.7002xru_A mol:protein length:280 SERINE/THREONINE-PROTEIN KINASE 6  ali model follow..  31  8.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 262
65 -77.6004DED Entity 1(prereleased)  ali follow..  31  9.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 263
66 -77.5003lau_A mol:protein length:287 Serine/threonine-protein kinase 6  ali model follow..  31  8.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 262
67 -77.3002wtv_A mol:protein length:285 SERINE/THREONINE-PROTEIN KINASE 6 AURORA/IPL1  ali model follow..  31  13.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 267
68 -77.3003nrm_A mol:protein length:283 Serine/threonine-protein kinase 6  ali model follow..  31  11.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 265
69 -77.1002c6e_A mol:protein length:283 SERINE/THREONINE-PROTEIN KINASE 6  ali model follow..  31  13.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 267
70 -77.0002dwb_A mol:protein length:285 Serine/threonine-protein kinase 6  ali model follow..  31  13.........EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA......................................................................................................................................................................................................................................................... 267
71 -76.9003d5u_A mol:protein length:317 Polo-like kinase 1  ali model follow..  33  42.........KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG........................................................................................................................................................................................................................................................ 299
72 -76.5002fh9_A mol:protein length:274 Snf1 kinase  ali model follow..  41  9..........NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK-----LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD........................................................................................................................................................................................................................................................ 264
73 -76.3002br1_A mol:protein length:297 SERINE/THREONINE-PROTEIN KINASE CHK1  ali model follow..  30  7.........EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNRLLNKMCGTLPYVAPELLKRREFAEPVDVWSCGIVLTAMLAGELPWDQPSDCQEYSDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP........................................................................................................................................................................................................................................................ 268
74 -76.3003dae_A mol:protein length:283 Carbon catabolite-derepressing protein kinase  ali model follow..  41  15..........NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK-----LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD........................................................................................................................................................................................................................................................ 270
75 -75.8002vrx_A mol:protein length:285 SERINE/THREONINE-PROTEIN KINASE 12-A  ali model follow..  28  15.........DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK......................................................................................................................................................................................................................................... 285

FFAS is supported by the NIH grant R01-GM087218-01
6 0 5 2 6   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Bourne PE, Allerston CK, Krebs W, Li W, Shindyalov IN, Godzik A.,Friedberg I, Liu T, Wild D, Hwang S, Ghahramani Z, Chen L, Westbrook J. The status of structural genomics defined through the analysis of current targets and structures. Pac Symp Biocomput. 2004;:375-86.